Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.74 USD | +5.10% | -7.03% | -41.08% |
05-09 | RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk | MT |
05-08 | Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.08% | 1.11B | |
+5.90% | 111B | |
+11.60% | 106B | |
-12.80% | 22.24B | |
-0.20% | 21.25B | |
-4.97% | 18.97B | |
-35.21% | 18.52B | |
-11.41% | 16.81B | |
+38.07% | 12.54B | |
-24.58% | 8.09B |
- Stock Market
- Equities
- PRTA Stock
- News Prothena Corporation plc
- Prothena Says Phase 3 Trial Data Showed Survival Benefit in People With AL Amyloidosis Treated With Birtamimab